Zobrazeno 1 - 10
of 297
pro vyhledávání: '"35"'
Autor:
Gian Francesco Gallino, Filiberto Belli, Francesca Valvo, Giuliano Bonfanti, Salvatore Andreola, Grazia Sirizzotti, Ermanno Leo, Paolo Greco, Gorana Tomasic
Publikováno v:
Annals of Surgical Oncology. 8:611-615
Recent reports suggest that a distal clearance (DC) of 10 mm at the lower surgical margin may be considered adequate in the surgical treatment of rectal cancer, but there are no data on the possible adequacy of a10-mm DC in N0 patients in whom a good
Autor:
Rinku Sutradhar, David R. McCready, May Lynn Quan, Fahima Osman, Lawrence Paszat, Kimberly A. Fernandes
Publikováno v:
Annals of surgical oncology. 21(2)
The utility of post mastectomy radiotherapy in very young women is understudied. The objective of this study was to evaluate the use of PMRT in very young women to determine the effect on recurrence and survival.All women aged ≤35 years diagnosed w
Autor:
Sue E. Blackwell, Ann M. Miller, Ann Tomanek-Chalkley, Kristen L Coleman, George J. Weiner, Carlos H. F. Chan, Katherine N Gibson-Corely, Caitlin D Lemke-Miltner
Publikováno v:
Ann Surg Oncol
BACKGROUND. The treatment options for patients with peritoneal carcinomatosis (PC) of gastrointestinal and pancreaticobiliary origins are limited. The virus-like particle, CMP-001, composed of the Qβ bacteriophage capsid protein encapsulating a CpG-
Publikováno v:
Annals of Surgical Oncology. 27:2248-2254
The National Comprehensive Cancer Network (NCCN) developed clinical practice guidelines for germline pathogenic variants in highly penetrant genes, such as TP53 and PTEN, and in moderately penetrant genes, such as CHEK2, ATM and PALB2. Whether the pr
Publikováno v:
Annals of Surgical Oncology. 24:733-738
Intraoperative parathyroid hormone (IOPTH) monitoring is crucial in the treatment of primary hyperparathyroidism (PHPT). Often, the 5 min IOPTH levels fall, but not by the requisite 50 %. In such cases, the surgeon must decide whether to wait for add
Publikováno v:
Annals of Surgical Oncology. 24:244-250
The optimal preoperative α-blockade strategy is debated for patients undergoing laparoscopic adrenalectomy for pheochromocytomas. We evaluated the impact of selective versus non-selective α-blockade on intraoperative hemodynamics and postoperative
Autor:
Harm J. T. Rutten, D. Wyndaele, A. J. G. Maaskant-Braat, Rudi M. H. Roumen, Adri C. Voogd, Ernest J. T. Luiten, E.J.Th. Rutgers, G.A.P. Nieuwenhuijzen, Guusje Vugts, Y. E. A. van Riet
Publikováno v:
Annals of Surgical Oncology, 22(Suppl. 3), S529-S535. Springer, Cham
Purpose. Repeat sentinel node biopsy (SNB) is an alternative to axillary lymph node dissection (ALND) for axillary staging in recurrent breast cancer. This study was conducted to determine factors associated with technical success of repeat SNB.Metho
Autor:
Yang Xie, William G. Rule, Takeshi Yokoo, Naama Lev-Cohain, Raquibul Hannan, Robert Timmerman, Jing Tian, Timothy D. Solberg, Roderich E. Schwarz, Ying Dong, Lucien A. Nedzi, Ryan D. Foster, Jeffrey J Meyer
Publikováno v:
Annals of Surgical Oncology
Background There is significant interest in the use of stereotactic ablative radiotherapy (SABR) as a treatment modality for liver metastases. A variety of SABR fractionation schemes are in clinical use. We conducted a phase I dose-escalation study t
Autor:
Stephanie Akbari, Lisette Stork-Sloots, Bichlien Nguyen, Angela Mislowsky, Paul Richards, Laura Lee, Peter D. Beitsch, Mark A. Gittleman, Michael Rotkis, Charles Nash, Femke A. de Snoo, P Whitworth, Jennifer Beatty, James Pellicane
Publikováno v:
Annals of Surgical Oncology
Purpose The purpose of the NBRST study is to compare a multigene classifier to conventional immunohistochemistry (IHC)/fluorescence in situ hybridization (FISH) subtyping to predict chemosensitivity as defined by pathological complete response (pCR)
Autor:
Peter J. Allen, Andrea Cercek, Nancy E. Kemeny, Derek G. Power, Yuman Fong, Marinela Capanu, Alexandra N. Gewirtz, William R. Jarnagin, Dina Patel, Michael I. D’Angelica, Ronald P. DeMatteo
Publikováno v:
Annals of Surgical Oncology. 21:479-486
Systemic bevacizumab (Bev) was added to hepatic arterial infusion (HAI) floxuridine (FUDR)-based chemotherapy in three studies in an attempt to improve outcomes. A specific review of biliary toxicity was carried out.This analysis included 203 patient